Drugs / nistatin
last change Apr 2023 re-read 2 minutes ago

nistatin

Developed for
bacterial infectious disease
Investigated by
MEDSI Clinical Hospital 1, ICU

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT04839653 May 2021 → Apr 2022 acute respiratory distress syndrome, bacterial infectious disease, infectious disease with sepsis, pneumonia MEDSI Clinical Hospital 1, ICU Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as nistatin ClinicalTrials.gov intervention name — accepted as the source's own label NCT04839653